CNE100001FF1
CNE100001FF1
BOYA BIOLOGY
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.059.088.027 | 1.734.904.403 | 18.7% |
| Cost of Revenue | 1.031.721.835 | 613.214.874 | 68.2% |
| Gross Profit | 1.027.366.192 | 1.121.689.529 | 8.4% |
| 685.304.150 | 656.720.012 | 4.4% | |
| Operating Income | 342.062.042 | 464.969.516 | 26.4% |
| Pretax Income | 103.878.495 | 477.713.553 | 78.3% |
| Net Income Common Stockholders | 112.698.349 | 396.991.589 | 71.6% |
| -- | -- | -- | |
| -- | -- | -- |